株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

北米における婦人科用医療機器市場の見通し

North America Gynecological Devices Market Outlook to 2023

発行 GlobalData 商品コード 312426
出版日 ページ情報 英文 163 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.05円で換算しております。
Back to Top
北米における婦人科用医療機器市場の見通し North America Gynecological Devices Market Outlook to 2023
出版日: 2017年05月01日 ページ情報: 英文 163 Pages
概要

当レポートでは、北米における婦人科用医療機器の売上および出荷量の実績と今後の予測、平均価格の推移を市場セグメント別に提供しています。また、各市場カテゴリーにおける企業シェアおよび流通シェアのデータ、主要企業のプロファイル、パイプライン製品、主な財務取引状況についての最新情報などをまとめています。

第1章 目次

第2章 イントロダクション

  • 本レポートについて
  • 婦人科用医療機器市場の分類
  • 本レポートの市場範囲と定義

第3章 婦人科用医療機器の北米市場

  • 婦人科用医療機器の北米市場:収益の実績と予測($m)
  • 婦人科用医療機器の北米市場:収益ベースでのカテゴリー比較の予測と実績($m)
  • 婦人科用医療機器の北米市場:収益の実績($m)
  • 婦人科用医療機器の北米市場:収益の予測($m)
  • 婦人科用医療機器の北米市場:出荷量の実績と予測
  • 婦人科用医療機器の北米市場:出荷量の実績
  • 婦人科用医療機器の北米市場:出荷量の予測
  • 婦人科用医療機器の北米市場:収益ベースの企業シェア($m)

第4章 婦人科用医療機器のカナダ市場

  • 婦人科用医療機器のカナダ市場:収益の実績($m)
  • 婦人科用医療機器のカナダ市場:収益の予測($m)
    • 女性用不妊手術装置のカナダ市場:セグメント別収益の実績($m)
    • 子宮内膜アブレーション装置のカナダ市場:セグメント別収益の実績($m)
    • 子宮筋腫塞栓物質のカナダ市場:セグメント別収益の実績($m)
    • 女性用不妊手術装置のカナダ市場:セグメント別収益の予測($m)
    • 子宮内膜アブレーション装置のカナダ市場:セグメント別収益の予測($m)
    • 子宮筋腫塞栓物質のカナダ市場:セグメント別収益の予測($m)
  • 婦人科用医療機器のカナダ市場:出荷量の実績
  • 婦人科用医療機器のカナダ市場:出荷量の予測
    • 女性用不妊手術装置のカナダ市場:セグメント別出荷量の実績
    • 子宮内膜アブレーション装置のカナダ市場:セグメント別出荷量の実績
    • 子宮筋腫塞栓物質のカナダ市場:セグメント別出荷量の実績
    • 女性用不妊手術装置のカナダ市場:セグメント別出荷量の予測
    • 子宮内膜アブレーション装置のカナダ市場:セグメント別出荷量の予測
    • 子宮筋腫塞栓物質のカナダ市場:セグメント別出荷量の予測
  • 婦人科用医療機器のカナダ市場:平均販売価格の推移
  • 婦人科用医療機器のカナダ市場:収益ベースの流通シェア($m)
  • 婦人科用医療機器のカナダ市場:収益ベースの企業シェア($m)

第5章 婦人科用医療機器のメキシコ市場

  • 婦人科用医療機器のメキシコ市場:収益の実績($m)
  • 婦人科用医療機器のメキシコ市場:収益の予測($m)
    • 女性用不妊手術装置のメキシコ市場:セグメント別収益の実績($m)
  • >
    • 子宮内膜アブレーション装置のメキシコ市場:セグメント別収益の実績($m)
    • 子宮筋腫塞栓物質のメキシコ市場:セグメント別収益の実績($m)
    • 女性用不妊手術装置のメキシコ市場:セグメント別収益の予測($m)
    • 子宮内膜アブレーション装置のメキシコ市場:セグメント別収益の予測($m)
    • 子宮筋腫塞栓物質のメキシコ市場:セグメント別収益の予測($m)
  • 婦人科用医療機器のメキシコ市場:出荷量の実績
  • 婦人科用医療機器のメキシコ市場:出荷量の予測
    • 女性用不妊手術装置のメキシコ市場:セグメント別出荷量の実績
    • 子宮内膜アブレーション装置のメキシコ市場:セグメント別出荷量の実績
    • 子宮筋腫塞栓物質のメキシコ市場:セグメント別出荷量の実績
    • 女性用不妊手術装置のメキシコ市場:セグメント別出荷量の予測
    • 子宮内膜アブレーション装置のメキシコ市場:セグメント別出荷量の予測
    • 子宮筋腫塞栓物質のメキシコ市場:セグメント別出荷量の予測
  • 婦人科用医療機器のメキシコ市場:平均販売価格の推移
  • 婦人科用医療機器のメキシコ市場:収益ベースの流通シェア($m)
  • 婦人科用医療機器のメキシコ市場:収益ベースの企業シェア($m)

第6章 婦人科用医療機器の米国市場

  • 婦人科用医療機器の米国市場:収益の実績($m)
  • 婦人科用医療機器の米国市場:収益の予測($m)
    • 女性用不妊手術装置の米国市場:セグメント別収益の実績($m)
    • 子宮内膜アブレーション装置の米国市場:セグメント別収益の実績($m)
    • 子宮筋腫塞栓物質の米国市場:セグメント別収益の実績($m)
    • 女性用不妊手術装置の米国市場:セグメント別収益の予測($m)
    • 子宮内膜アブレーション装置の米国市場:セグメント別収益の予測($m)
    • 子宮筋腫塞栓物質の米国市場:セグメント別収益の予測($m)
  • 婦人科用医療機器の米国市場:出荷量の実績
  • 婦人科用医療機器の米国市場:出荷量の予測
    • 女性用不妊手術装置の米国市場:セグメント別出荷量の実績
    • 子宮内膜アブレーション装置の米国市場:セグメント別出荷量の実績
    • 子宮筋腫塞栓物質の米国市場:セグメント別出荷量の実績
    • 女性用不妊手術装置の米国市場:セグメント別出荷量の予測
    • 子宮内膜アブレーション装置の米国市場:セグメント別出荷量の予測
    • 子宮筋腫塞栓物質の米国市場:セグメント別出荷量の予測
  • 婦人科用医療機器の米国市場:平均販売価格の推移
  • 婦人科用医療機器の米国市場:収益ベースの流通シェア($m)
  • 婦人科用医療機器の米国市場:収益ベースの企業シェア($m)

第7章 北米の婦人科用医療機器市場における主要企業の概要

  • Conceptus, Inc.
  • Hologic, Inc.
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • CooperSurgical, Inc.
  • Merit Medical Systems, Inc.
  • Utah Medical Products, Inc.
  • Johnson & Johnson
  • BSD Medical Corporation

第8章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECR0575DB

GlobalData's new report, "North America Gynecological Devices Market Outlook to 2023", provides key market data on the North America Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Gynecological Devices market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the North America Gynecological Devices market.
  • Key players covered include Hologic Inc, CooperSurgical Inc, Ethicon Inc and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 9

  • 2.1 What Is This Report About? 9
  • 2.2 Gynecological Devices Market Segmentation 9
  • 2.3 Definitions of Markets Covered in the Report 10

3 Gynecological Devices Market, North America 12

  • 3.1 Gynecological Devices Market, North America, Revenue ($m), 2009-2023 12
  • 3.2 Gynecological Devices Market, North America, Revenue ($m), 2009-2016 14
  • 3.3 Gynecological Devices Market, North America, Revenue ($m), 2016-2023 16
  • 3.4 Gynecological Devices Market, North America, Volume (Units), 2009-2023 18
  • 3.5 Gynecological Devices Market, North America, Volume (Units), 2009-2016 20
  • 3.6 Gynecological Devices Market, North America, Volume (Units), 2016-2023 22
  • 3.7 Gynecological Devices Market, North America, Company Share by Revenue ($m), 2016 24

4 Gynecological Devices Market, Canada 26

  • 4.1 Gynecological Devices Market, Canada, Revenue ($m), by Segment, 2009-2016 26
  • 4.2 Gynecological Devices Market, Canada, Revenue ($m) by Segment, 2016-2023 28
    • 4.2.1 Endometrial Ablation Devices Market, Canada, Revenue ($m), by Segment, 2009-2016 30
    • 4.2.2 Female Sterilization Devices Market, Canada, Revenue ($m), by Segment, 2009-2016 32
    • 4.2.3 Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m), by Segment, 2009-2016 34
    • 4.2.4 Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m), by Segment, 2009-2016 35
    • 4.2.5 Endometrial Ablation Devices Market, Canada, Revenue ($m) by Segment, 2016-2023 37
    • 4.2.6 Female Sterilization Devices Market, Canada, Revenue ($m) by Segment, 2016-2023 39
    • 4.2.7 Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m) by Segment, 2016-2023 41
    • 4.2.8 Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m) by Segment, 2016-2023 42
  • 4.3 Gynecological Devices Market, Canada, Volume (Units) by Segment, 2009-2016 44
  • 4.4 Gynecological Devices Market, Canada, Volume (Units) by Segment, 2016-2023 46
    • 4.4.1 Endometrial Ablation Devices Market, Canada, Volume (Units) by Segment, 2009-2016 48
    • 4.4.2 Female Sterilization Devices Market, Canada, Volume (Units) by Segment, 2009-2016 50
    • 4.4.3 Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) by Segment, 2009-2016 52
    • 4.4.4 Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) by Segment, 2009-2016 53
    • 4.4.5 Endometrial Ablation Devices Market, Canada, Volume (Units) by Segment, 2016-2023 55
    • 4.4.6 Female Sterilization Devices Market, Canada, Volume (Units) by Segment, 2016-2023 57
    • 4.4.7 Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) by Segment, 2016-2023 59
    • 4.4.8 Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) by Segment, 2016-2023 60
  • 4.5 Gynecological Devices Market, Canada, Average Price ($), 2009-2023 62
  • 4.6 Gynecological Devices Market, Canada, Distribution Share by Revenue ($m), 2016 64
  • 4.7 Gynecological Devices Market, Canada, Company Share by Revenue ($m), 2016 65

5 Gynecological Devices Market, Mexico 67

  • 5.1 Gynecological Devices Market, Mexico, Revenue ($m), 2009-2016 67
  • 5.2 Gynecological Devices Market, Mexico, Revenue ($m), 2016-2023 69
    • 5.2.1 Endometrial Ablation Devices Market, Mexico, Revenue ($m), by Segment, 2009-2016 71
    • 5.2.2 Female Sterilization Devices Market, Mexico, Revenue ($m), by Segment, 2009-2016 73
    • 5.2.3 Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), by Segment, 2009-2016 75
    • 5.2.4 Endometrial Ablation Devices Market, Mexico, Revenue ($m), by Segment, 2016-2023 77
    • 5.2.5 Female Sterilization Devices Market, Mexico, Revenue ($m), by Segment, 2016-2023 79
    • 5.2.6 Uterine Fibroid Ablation Devices Market, Mexico, Revenue ($m), by Segment, 2016-2023 81
    • 5.2.7 Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), by Segment, 2016-2023 82
  • 5.3 Gynecological Devices Market, Mexico, Volume (Units), 2009-2016 84
  • 5.4 Gynecological Devices Market, Mexico, Volume (Units), 2016-2023 86
    • 5.4.1 Endometrial Ablation Devices Market, Mexico, Volume (Units), by Segment, 2009-2016 88
    • 5.4.2 Female Sterilization Devices Market, Mexico, Volume (Units), by Segment, 2009-2016 90
    • 5.4.3 Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), by Segment, 2009-2016 92
    • 5.4.4 Endometrial Ablation Devices Market, Mexico, Volume (Units), by Segment, 2016-2023 94
    • 5.4.5 Female Sterilization Devices Market, Mexico, Volume (Units), by Segment, 2016-2023 96
    • 5.4.6 Uterine Fibroid Ablation Devices Market, Mexico, Volume (Units), by Segment, 2016-2023 98
    • 5.4.7 Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), by Segment, 2016-2023 99
  • 5.5 Gynecological Devices Market, Mexico, Average Price ($), 2009-2023 101
  • 5.6 Gynecological Devices Market, Mexico, Distribution Share by Revenue ($m), 2016 103
  • 5.7 Gynecological Devices Market, Mexico, Company Share by Revenue ($m), 2016 104

6 Gynecological Devices Market, United States 106

  • 6.1 Gynecological Devices Market, United States, Revenue ($m), 2009-2016 106
  • 6.2 Gynecological Devices Market, United States, Revenue ($m), 2016-2023 108
    • 6.2.1 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016 110
    • 6.2.2 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2009-2016 112
    • 6.2.3 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016 114
    • 6.2.4 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2009-2016 115
    • 6.2.5 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023 117
    • 6.2.6 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2016-2023 119
    • 6.2.7 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023 121
    • 6.2.8 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2016-2023 122
  • 6.3 Gynecological Devices Market, United States, Volume (Units), 2009-2016 124
  • 6.4 Gynecological Devices Market, United States, Volume (Units), 2016-2023 126
    • 6.4.1 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016 128
    • 6.4.2 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2009-2016 130
    • 6.4.3 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016 132
    • 6.4.4 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2009-2016 133
    • 6.4.5 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023 135
    • 6.4.6 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2016-2023 137
    • 6.4.7 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023 139
    • 6.4.8 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2016-2023 140
  • 6.5 Gynecological Devices Market, United States, Average Price ($), 2009-2023 142
  • 6.6 Gynecological Devices Market, United States, Distribution Share by Revenue ($m), 2016 144
  • 6.7 Gynecological Devices Market, United States, Company Share by Revenue ($m), 2016 145

7 Overview of Key Companies in North America Gynecological Devices Market 147

  • 7.1 Bayer AG 147
    • 7.1.1 Company Overview 147
  • 7.2 Hologic Inc 147
    • 7.2.1 Company Overview 147
  • 7.3 Utah Medical Products, Inc. 147
    • 7.3.1 Company Overview 147
  • 7.4 CooperSurgical Inc 148
    • 7.4.1 Company Overview 148
  • 7.5 Ethicon Inc 148
    • 7.5.1 Company Overview 148
  • 7.6 Boston Scientific Corp 148
    • 7.6.1 Company Overview 148
  • 7.7 Merit Medical Systems, Inc. 149
    • 7.7.1 Company Overview 149
  • 7.8 Cook Group Inc 149
    • 7.8.1 Company Overview 149

8 Gynecological Devices Market Pipeline Products 150

9 Recent Developments 151

  • 9.1 Corporate Communications 151
    • 9.1.1 Nov 15, 2016: Cynosure Health Welcomes Three New Board Members 151
    • 9.1.2 Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer 151
    • 9.1.3 Sep 13, 2016: Cynosure to Name Stephen J. Webber as New Chief Financial Officer 152
    • 9.1.4 May 25, 2016: Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer 152
  • 9.2 Financial Announcements 153
    • 9.2.1 Feb 07, 2017: Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year 153
    • 9.2.2 Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million 154
    • 9.2.3 Jul 26, 2016: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016 155

10 Appendix 157

  • 10.1 Research Methodology 158
    • 10.1.1 Coverage 158
    • 10.1.2 Secondary Research 158
    • 10.1.3 Primary Research 159
    • 10.1.4 Market Modeling and Forecasting 160
    • 10.1.5 Company Share Analysis 161
    • 10.1.6 Distribution Share Analysis 162
    • 10.1.7 Benchmarking 162
  • 10.2 GlobalData Consulting 162
  • 10.3 Contact Us 163
  • 10.4 Disclaimer 163

List of Tables

1.1 List of Tables

  • Table 1: Gynecological Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023 13
  • Table 2: Gynecological Devices Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016 15
  • Table 3: Gynecological Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023 17
  • Table 4: Gynecological Devices Market, North America, Volume (Units), 2009-2023 19
  • Table 5: Gynecological Devices Market, North America, Volume (Units), Historic, 2009-2016 21
  • Table 6: Gynecological Devices Market, North America, Volume (Units), Forecast, 2016-2023 23
  • Table 7: Gynecological Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2016 25
  • Table 8: Gynecological Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 27
  • Table 9: Gynecological Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 29
  • Table 10: Endometrial Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 31
  • Table 11: Female Sterilization Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 33
  • Table 12: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 34
  • Table 13: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 36
  • Table 14: Endometrial Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 38
  • Table 15: Female Sterilization Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 40
  • Table 16: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 41
  • Table 17: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 43
  • Table 18: Gynecological Devices Market, Canada, Volume (Units) , Historic, 2009-2016 45
  • Table 19: Gynecological Devices Market, Canada, Volume (Units) , Forecast, 2016-2023 47
  • Table 20: Endometrial Ablation Devices Market, Canada, Volume (Units) , Historic, 2009-2016 49
  • Table 21: Female Sterilization Devices Market, Canada, Volume (Units) , Historic, 2009-2016 51
  • Table 22: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) , Historic, 2009-2016 52
  • Table 23: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) , Historic, 2009-2016 54
  • Table 24: Endometrial Ablation Devices Market, Canada, Volume (Units) , Forecast, 2016-2023 56
  • Table 25: Female Sterilization Devices Market, Canada, Volume (Units) , Forecast, 2016-2023 58
  • Table 26: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) , Forecast, 2016-2023 59
  • Table 27: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) , Forecast, 2016-2023 61
  • Table 28: Gynecological Devices Market, Canada, Average Price ($) Historic, 2009-2016 62
  • Table 29: Gynecological Devices Market, Canada, Average Price ($), Forecast, 2016-2023 63
  • Table 30: Gynecological Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2016 64
  • Table 31: Gynecological Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 66
  • Table 32: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 68
  • Table 33: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 70
  • Table 34: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 72
  • Table 35: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 74
  • Table 36: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 76
  • Table 37: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 78
  • Table 38: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 80
  • Table 39: Uterine Fibroid Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 81
  • Table 40: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 83
  • Table 41: Gynecological Devices Market, Mexico, Volume (Units), Historic, 2009-2016 85
  • Table 42: Gynecological Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 87
  • Table 43: Endometrial Ablation Devices Market, Mexico, Volume (Units), Historic, 2009-2016 89
  • Table 44: Female Sterilization Devices Market, Mexico, Volume (Units), Historic, 2009-2016 91
  • Table 45: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Historic, 2009-2016 93
  • Table 46: Endometrial Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 95
  • Table 47: Female Sterilization Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 97
  • Table 48: Uterine Fibroid Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 98
  • Table 49: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Forecast, 2016-2023 100
  • Table 50: Gynecological Devices Market, Mexico, Average Price ($) Historic, 2009-2016 101
  • Table 51: Gynecological Devices Market, Mexico, Average Price ($), Forecast, 2016-2023 102
  • Table 52: Gynecological Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2016 103
  • Table 53: Gynecological Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2016 105
  • Table 54: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 107
  • Table 55: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 109
  • Table 56: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 111
  • Table 57: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 113
  • Table 58: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 114
  • Table 59: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 116
  • Table 60: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 118
  • Table 61: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 120
  • Table 62: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 121
  • Table 63: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 123
  • Table 64: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016 125
  • Table 65: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023 127
  • Table 66: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 129
  • Table 67: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016 131
  • Table 68: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 132
  • Table 69: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016 134
  • Table 70: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 136
  • Table 71: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023 138
  • Table 72: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 139
  • Table 73: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023 141
  • Table 74: Gynecological Devices Market, United States, Average Price ($) Historic, 2009-2016 142
  • Table 75: Gynecological Devices Market, United States, Average Price ($), Forecast, 2016-2023 143
  • Table 76: Gynecological Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016 144
  • Table 77: Gynecological Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 146
  • Table 78: Gynecological Devices Market Pipeline Products 150
  • Table 79: Total Number of Primary Research Participants General Surgery Market, by Country 160

List of Figures

1.2 List of Figures

  • Figure 1: Gynecological Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023 12
  • Figure 2: Gynecological Devices Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016 14
  • Figure 3: Gynecological Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023 16
  • Figure 4: Gynecological Devices Market, North America, Volume (Units), 2009-2023 18
  • Figure 5: Gynecological Devices Market, North America, Volume (Units), Historic, 2009-2016 20
  • Figure 6: Gynecological Devices Market, North America, Volume (Units), Forecast, 2016-2023 22
  • Figure 7: Gynecological Devices Market, North America, Company Share (%) 2016 24
  • Figure 8: Gynecological Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 26
  • Figure 9: Gynecological Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 28
  • Figure 10: Endometrial Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 30
  • Figure 11: Female Sterilization Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 32
  • Figure 12: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 34
  • Figure 13: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 35
  • Figure 14: Endometrial Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 37
  • Figure 15: Female Sterilization Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 39
  • Figure 16: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 41
  • Figure 17: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 42
  • Figure 18: Gynecological Devices Market, Canada, Volume (Units), Historic, 2009-2016 44
  • Figure 19: Gynecological Devices Market, Canada, Volume (Units), Forecast, 2016-2023 46
  • Figure 20: Endometrial Ablation Devices Market, Canada, Volume (Units), Historic, 2009-2016 48
  • Figure 21: Female Sterilization Devices Market, Canada, Volume (Units), Historic, 2009-2016 50
  • Figure 22: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units), Historic, 2009-2016 52
  • Figure 23: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units), Historic, 2009-2016 53
  • Figure 24: Endometrial Ablation Devices Market, Canada, Volume (Units), Forecast, 2016-2023 55
  • Figure 25: Female Sterilization Devices Market, Canada, Volume (Units), Forecast, 2016-2023 57
  • Figure 26: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units), Forecast, 2016-2023 59
  • Figure 27: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units), Forecast, 2016-2023 60
  • Figure 28: Gynecological Devices Market, Canada, Company Share (%) 2016 65
  • Figure 29: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 67
  • Figure 30: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 69
  • Figure 31: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 71
  • Figure 32: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 73
  • Figure 33: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 75
  • Figure 34: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 77
  • Figure 35: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 79
  • Figure 36: Uterine Fibroid Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 81
  • Figure 37: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 82
  • Figure 38: Gynecological Devices Market, Mexico, Volume (Units), Historic, 2009-2016 84
  • Figure 39: Gynecological Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 86
  • Figure 40: Endometrial Ablation Devices Market, Mexico, Volume (Units), Historic, 2009-2016 88
  • Figure 41: Female Sterilization Devices Market, Mexico, Volume (Units), Historic, 2009-2016 90
  • Figure 42: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Historic, 2009-2016 92
  • Figure 43: Endometrial Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 94
  • Figure 44: Female Sterilization Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 96
  • Figure 45: Uterine Fibroid Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 98
  • Figure 46: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Forecast, 2016-2023 99
  • Figure 47: Gynecological Devices Market, Mexico, Company Share (%) 2016 104
  • Figure 48: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 106
  • Figure 49: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 108
  • Figure 50: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 110
  • Figure 51: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 112
  • Figure 52: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 114
  • Figure 53: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 115
  • Figure 54: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 117
  • Figure 55: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 119
  • Figure 56: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 121
  • Figure 57: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 122
  • Figure 58: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016 124
  • Figure 59: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023 126
  • Figure 60: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 128
  • Figure 61: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016 130
  • Figure 62: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 132
  • Figure 63: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016 133
  • Figure 64: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 135
  • Figure 65: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023 137
  • Figure 66: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 139
  • Figure 67: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023 140
  • Figure 68: Gynecological Devices Market, United States, Company Share (%) 2016 145
Back to Top